WHO warns cancer cases to nearly double by 2050
Analysis based on 40 articles · First reported Mar 09, 2018 · Last updated Jul 13, 2026
The report may increase focus on healthcare spending and cancer prevention, potentially benefiting pharmaceutical and diagnostic companies. However, the projected rise in cases could strain healthcare systems and insurance markets, leading to negative sentiment for insurers and public health budgets.
The World Health Organization (WHO), jointly with the International — International Agency for Research on Cancer (IARC), released the Global Status Report on Cancer 2026 on July 8, 2026. The report warns that annual cancer cases could rise from 20.6 million in 2024 to nearly 35 million by 2050 without urgent action. Cancer currently causes nearly 10 million deaths annually, making it the second leading cause of death globally. The report highlights stark inequalities: 87% of women with breast cancer survive five years in high-income countries versus 42% in low-income countries. Fewer than one in three countries include cancer care in universal health coverage. Preventable risk factors (tobacco, alcohol, obesity, infections) account for nearly 40% of cases. WHO Director-General Tedros Adhanom Ghebreyesus stated that survival should not depend on birthplace or income. The report also notes progress: tobacco use declined 27% since 2010, 85% of countries have HPV vaccines, and 82% have national cancer plans. However, access to essential medicines remains unequal, and obesity is an emerging driver. The report calls for a people-centered approach integrating cancer care into universal health coverage.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard